October 03, 2012

Sanofi and Bristol-Myers Squibb Announce Restructuring of Alliance Agreement

- Revised Agreement Simplifies Alliance by Streamlining Operational Responsibilities Consistent with Each Company’s Strategic Priorities -.

 

Sanofi and Bristol-Myers Squibb Announce Restructuring of Alliance Agreement
- Revised Agreement Simplifies Alliance by Streamlining Operational Responsibilities Consistent with Each Company’s Strategic Priorities -.

Paris, France, and New York, NY- October 3, 2012 – Sanofi (EURONEXT: SAN and NYSE: SNY) and Bristol-Myers Squibb Company (NYSE: BMY) today announced they have restructured their successful long-term alliance following the loss of exclusivity of Plavix and Avapro/Avalide in many major markets.